神经妥乐平治疗过敏性皮肤病

Neurotropin for allergic dermatoses

  • 摘要: 神经妥乐平注射剂3ml(支),肌注,1/d,共10次。84例中,女50例,男34例。慢性湿疹41例,过敏性皮炎19例,荨麻疹20例,其它皮肤病4例。2周疗效判定,显效28例(33.3%),有效25例(29.8%),有效率为63.1%。84例中发生不良反应4例,不良反应发生率为4.8%。本次临床验证的结果与日本作者的原始报告结果非常接近。本文工作经神经妥乐平临床验证专家委员会审评通过。

     

    Abstract: From August thrugh November 1994,a clinical investigation of the efficacy and safety of “NEU-ROTROPIN”(a biological product) ,was conducted involving 84 patients(50 females and 34 males) with various deramtoses including chronic eczema 41 cases,allergic dermatitis 19 cases,urticaria 20 case and other dermatoses 4 cases.Each patient was given 3 ml of “neurotropin”daily injected intramuscularly for a perird of 2 weeks. Clinical response as assessed after a 2 week course of treatment was“remarkable”in 28 cases(33.3%) and “effective”in 25 cases(29.8%) .with a total effective rate of 63.1%. Untoward reactions occurred in 4 of 84 cases(4.8%) .The result of the present study closely resembles that in the preliminany report in the Japanese literature.

     

/

返回文章
返回